Skip to content

Clinical trials

Observational Lymphoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Observational Country / region: China Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20101
20111
20121
20131
20162
20171
20183
20194
20201
20215
20228
20237
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting16
Completed13
Unknown status12
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ruijin Hospital8
Sun Yat-sen University3
Takeda3
National Cancer Institute (NCI)2
Peking University Cancer Hospital & Institute2
Beijing Friendship Hospital1
Chinese PLA General Hospital1
First Affiliated Hospital of Harbin Medical University1
Ge Zheng1
Guangxi Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma43
Leukemia5
Leukemia, Myeloid, Acute5
Multiple Myeloma4
Myelodysplastic Syndromes4
Lung Neoplasms3
Lymphoma, Follicular3
Anemia, Aplastic2
Breast Neoplasms2
Hematologic Diseases2

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.